A latest report has been added to the wide database of Transcatheter Mitral Valve Replacement Market by Infinium Global Research. This report studies the Transcatheter Mitral Valve Replacement Market by product (transapical implantation and transfemoral implantation), region (Americas, Europe, Asia-Pacific, and Rest of the World) market status and outlook of global and major regions, from manufacturers, and end industries. The objective of the study is to identify market sizes of different segments & countries in recent years and to forecast the values for the next six years. Transcatheter Mitral Valve Replacement Market provides opportunities in micro markets for stakeholders to invest along with the detailed analysis of competitive landscape, latest trends, and product offerings of the major companies in the Transcatheter Mitral Valve Replacement Market. According to report the global transcatheter mitral valve replacement market is projected to grow at a CAGR of 17.9% over the forecast period of 2017-2023.
The mitral valve, also known as the bicuspid valve or left atrio-ventricular valve, is a dual-flap valve in the heart that lies between the left atrium and the left ventricle. The mitral valve and the tricuspid valve are known collectively as the atrio-ventricular valves because they lie between the atria and the ventricles of the heart. The mitral valve manages blood flow between left atrium and left ventricle; and prevents backward flow of the blood into left atrium. Mitral regurgitation is leakage of blood backward through the mitral valve each time the left ventricle contracts. This is a most common mitral valve disorder that causes abnormal blood flow. As a remedy for this problem, surgeons use mitral surgical vale repair procedures or transcatheter replacement methods.
Some of the key driving factors attributing to the growth of this market include increasing number of patients with mitral valve disorders. Approximately 7 million people in the U.S. suffer from mitral regurgitation in the U.S., and they represent almost 2% of the nation's population. Similarly, approximately the same number of people suffers from the condition in Europe. This group includes 4.1 million people who have moderate to severe mitral regurgitation. The number of new patients suffering with mitral regurgitation disease added each year is 250,000. Among these 4.1 million patients, only about 20% or 1.67 million are eligible for the treatment. This creates huge opportunity for the global transcatheter mitral valve replacement market.
In addition, increasing adoption of minimally invasive procedures over traditional surgical open heart procedures, reduction in hospital stays, low risk of infection, minimal blood loss are further propelling the market. According to world health organization (WHO), it has been estimated that the number of people suffering from cardiovascular diseases will increase to 22.2 million by 2030. The market for TMVR is expected to reach around USD 3.0 billion by 2022. However, there are certain restraining factors which could hamper the growth of this market, which includes, high costs associated with the LMVD implantation compared to other therapies available for CVD diseases.
The report on global transcatheter mitral valve replacement market covers product segment. On the basis of product the global transcatheter mitral valve replacement market is categorized into transapical implantation and transfemoral implantation.
The report provides regional analysis covering geographies such as Americas, Europe, Asia-Pacific, and Rest of the World. In this section the key trends and market size for each geography is provided over the period of 2015-2023. The countries covered in the North America region include the U.S., Canada, and Mexico; while Asia-Pacific includes China, Japan, India, South Korea, Malaysia, and among others. Moreover, Germany, U.K., France, Spain, and Rest of Europe are included in the European region. The U.S. drives the growth in the North America region as it is the largest market in the region. The Asia-pacific region offers a substantial potential for the market growth owing to rapid growth in markets such as India and China. The APAC region is projected to experience a growth at a CAGR of x.x% over the period of 2017-2023.
The report provides profiles of the companies in the global transcatheter mitral valve replacement market such as, Abbott Laboratories, Edward Lifecsiences Incorporation, Micro Interventional Devices, Neovasc, Medtronic, Biotronik SE & Co. KG, Colibri Heart Valve, Llc., Livanova Plc, Neochord Inc. and Coramaze Technologies Gmbh.
The report provides deep insights on demand forecasts, market trends and micro and macro indicators. In addition, this report provides insights on the factors that are driving and restraining the global transcatheter mitral valve replacement market. Moreover, IGR-Growth Matrix analysis given in the report brings an insight on the investment areas that existing or new market players can consider. The report provides insights into the market using analytical tools such as Porter's five forces analysis and DRO analysis of transcatheter mitral valve replacement market. Moreover, the study highlights current market trends and provides forecast from 2017-2023. We also have highlighted future trends in the transcatheter mitral valve replacement market that will impact the demand during the forecast period. Moreover, the competitive analysis given in each regional market brings an insight on the market share of the leading players. This report will help manufacturers, suppliers and distributors of the transcatheter mitral valve replacement market to understand the present and future trends in this market and formulate their strategies accordingly.
Table of Contents:-
1.1. Report Description
1.2. Research Methods
1.3. Research Approaches
2. Executive Summary
3. Global Transcatheter Mitral Valve Replacement Market Overview
3.2. Market Dynamics
3.3. Porter's Five Forces Analysis
3.4. IGR-Growth Matrix Analysis
3.5. Competitive Landscape in the Global Transcatheter Mitral Valve Replacement Market
4. Global Transcatheter Mitral Valve Replacement Market by Product
4.1. Transapical Implantation
4.2. Transfemoral Implantation
5. Global Transcatheter Mitral Valve Replacement Market by Region 2017-2023
5.1.1. Americas Transcatheter Mitral Valve Replacement Market by Product
5.1.2. Americas Transcatheter Mitral Valve Replacement Market by Country
5.2.1. Europe Transcatheter Mitral Valve Replacement Market by Product
5.2.2. Europe Transcatheter Mitral Valve Replacement Market by Country
5.3.1. Asia-Pacific Transcatheter Mitral Valve Replacement Market by Product
5.3.2. Asia-Pacific Transcatheter Mitral Valve Replacement Market by Country
5.4.1. RoW Transcatheter Mitral Valve Replacement Market by Product
5.4.2. RoW Transcatheter Mitral Valve Replacement Market by Sub-region
6. Company Covered
6.1. Abbott Laboratories
6.2. Edward Lifecsiences Incorporation
6.3. Micro Interventional Devices
6.6. Biotronik SE & Co. KG
6.7. Colibri Heart Valve, Llc.
6.8. Livanova Plc
6.9. Neochord Inc.
6.10. Coramaze Technologies Gmbh.
Click the Below Full Report Link